|
|
Heyu Ni, Cécile V. Denis, Sangeetha Subbarao, Jay L. Degen, Thomas N. Sato, Richard O. Hynes, Denisa D. Wagner
J Clin Invest. 2000;
106(3):385
doi:10.1172/JCI9896
Abstract |
Full text
| PDF
W
e used intravital microscopy to observe the formation of platelet plugs in ferric chloride–injured arterioles of live mice. With this model, we evaluated thrombus growth in mice lacking von Willebrand factor (vWF) and fibrinogen (Fg), the two key ligands known to mediate platelet adhesion and aggregation. In vWF–/– mice, despite the presence of arterial shear, delayed platelet adhesion occurred and stable thrombi formed. In many mice, a persisting high-shear channel never occluded. Abundant thrombi formed in Fg–/– mice, but they detached from the subendothelium, which ultimately caused downstream occlusion in all cases. Surprisingly, mice deficient in both vWF and Fg successfully formed thrombi with properties characteristic of both mutations, leading to vessel occlusion in the majority of vessels. Platelets of these doubly deficient mice specifically accumulated fibronectin in their α-granules, suggesting that fibronectin could be the ligand supporting the platelet aggregation.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation : Platelet homotypic and heterotypic aggregation
Gabriella Passacquale, Albert Ferro |
Br J Clin Pharmacol |
2011 |
.
|
Polymers for the rapid and effective activation and aggregation of platelets
Anne Hansen, Loraine McMillan, Alex Morrison, Juraj Petrik, Mark Bradley |
Biomaterials 2000 |
2011 |
.
|
Patients with liver cirrhosis suffer from primary hemostatic defects? Fact or fiction?
F. Violi, S. Basili, V. Raparelli, P. Chowdary, A. Gatt, A.K. Burroughs |
JHepatol |
2011 |
.
|
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice
Junmei Chen, Adili Reheman, Francisca C. Gushiken, Leticia Nolasco, Xiaoyun Fu, Joel L. Moake, Heyu Ni, José A. López |
Journal Clinical Investigation |
2011 |
.
|
Platelet Chemokines and Chemokine Receptors: Linking Hemostasis, Inflammation, and Host Defense
ADRIAN R.L. GEAR, DAVID CAMERINI |
Microcirculation |
2010 |
.
|
The kinetics of IIb 3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy
M. Stolla, L. Stefanini, R. C. Roden, M. Chavez, J. Hirsch, T. Greene, T. D. Ouellette, S. F. Maloney, S. L. Diamond, M. Poncz, D. S. Woulfe, W. Bergmeier |
Blood |
2010 |
.
|
Platelet receptor signaling in thrombus formation
David Stegner, Bernhard Nieswandt |
J Mol Med-JMM |
2010 |
.
|
Samuel Chackalamannil |
Burger's Medicinal Chemistry and Drug Discovery |
2010 |
.
|
Inherited disorders of platelet function and challenges to diagnosis of mucocutaneous bleeding
S. J. ISRAELS, M. EL-EKIABY, T. QUIROGA, D. MEZZANO |
Hemophilia |
2010 |
.
|
Calcium-dependent platelet aggregation through the interaction between phosphatidylserine and LOX-1
K. Otsui, M. Kakutani, K. Yuasa, A. Nakano, C.-P. Hu, A. Kakino, Y. Sato, Y. Fujita, Y. Kawase, K.-i. Jishage, H. Suzuki, J. L. Mehta, M. Yokoyama, K.-i. Hirata, N. Inoue, T. Sawamura |
cardiovas res |
2010 |
.
|
A ferric chloride induced arterial injury model used as haemostatic effect model
F. MØLLER, M. TRANHOLM |
Hemophilia |
2010 |
.
|
Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression
H. Yang, S. Lang, Z. Zhai, L. Li, W. H. A. Kahr, P. Chen, J. Brkic, C. M. Spring, M. J. Flick, J. L. Degen, J. Freedman, H. Ni |
Blood |
2009 |
.
|
The Effects of Fibrinogen Levels on Thromboelastometric Variables in the Presence of Thrombocytopenia
Thomas Lang, Kai Johanning, Helfried Metzler, Siegfried Piepenbrock, Cristina Solomon, Niels Rahe-Meyer, Kenichi A. Tanaka |
Aneth Analg |
2009 |
.
|
Deficiency of von Willebrand factor protects mice from ischemic stroke
C. Kleinschnitz, S. F. De Meyer, T. Schwarz, M. Austinat, K. Vanhoorelbeke, B. Nieswandt, H. Deckmyn, G. Stoll |
Blood |
2009 |
.
|
Platelets and innate immunity
John W. Semple, John Freedman |
Experientia [Basel] |
2009 |
.
|
A deep intronic mutation inFGBcreates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment
Ryan L. Davis, Vivienne M. Homer, Peter M. George, Stephen O. Brennan |
Human Mutat |
2009 |
.
|
Platelet adhesion to multimerin 1in vitro: influences of platelet membrane receptors, von Willebrand factor and shear
S. TASNEEM, F. ADAM, I. MINULLINA, M. PAWLIKOWSKA, S. K. HUI, S. ZHENG, J. L. MILLER, C. P. M. HAYWARD |
J Thrombosis Haemostasis |
2009 |
.
|
von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke
B.-Q. Zhao, A. K. Chauhan, M. Canault, I. S. Patten, J. J. Yang, M. Dockal, F. Scheiflinger, D. D. Wagner |
Blood |
2009 |
.
|
Dynamics of platelet thrombus formation
S. P. JACKSON, W. S. NESBITT, E. WESTEIN |
J Thrombosis Haemostasis |
2009 |
.
|
Transforming growth factor- -induced protein (TGFBIp/ ig-h3) activates platelets and promotes thrombogenesis
H.-J. Kim, P.-K. Kim, S. M. Bae, H.-N. Son, D. S. Thoudam, J.-E. Kim, B.-H. Lee, R.-W. Park, I.-S. Kim |
Blood |
2009 |
.
|
|
|
|